Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Exp Eye Res ; 190: 107889, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-31801686

RESUMO

Pre-harvest burning of sugarcane fields produces large amounts of air pollutants which are known to cause health problems, including ocular surface abnormalities. In this study, we evaluated the effect of biomass burning on mucus quality and mucin gene expression (MUC1, MUC5AC, MUC16) in the conjunctiva of sugarcane workers (SWs) and residents of an adjacent town (RTs). Impression cytology samples of the inferior tarsal and bulbar conjunctiva of 78 SWs and 32 RTs were collected before (T1) and immediately after (T2) a 6-month harvest period. The neutral, acid and total mucus content of goblet cells was determined by PAS and AB staining. The levels of MUC5AC, MUC1 and MUC16 mRNA in the conjunctiva were measured by real-time PCR. Compared to RTs, SWs had higher levels of bulbar acid mucus and MUC16 mRNA and tarsal MUC5AC mRNA at T2 and lower levels of neutral mucus at T1 and T2. In the SW group, MUC1 mRNA levels were higher at T2 than at T1, but the levels of neutral and acid mucus were similar. In the RT group, acid mucus decreased and neutral mucus increased in the bulbar and tarsal conjunctiva at T2. In conclusion, our findings show that sugarcane harvesting is associated with abnormalities in mucus quality and content and changes in mucin mRNA levels on the ocular surface. This may help explain the ocular inflammatory signs and symptoms observed in subjects exposed to air pollutants and high temperatures from sugarcane biomass burning.


Assuntos
Poluentes Ocupacionais do Ar/toxicidade , Antígeno Ca-125/genética , Túnica Conjuntiva/efeitos dos fármacos , Proteínas de Membrana/genética , Mucina-5AC/genética , Mucina-1/genética , Exposição Ocupacional/efeitos adversos , Saccharum , Adulto , Agricultura , Biomassa , Brasil , Túnica Conjuntiva/metabolismo , Conjuntivite/induzido quimicamente , Conjuntivite/diagnóstico , Conjuntivite/metabolismo , Regulação da Expressão Gênica/fisiologia , Células Caliciformes/efeitos dos fármacos , Células Caliciformes/patologia , Humanos , Masculino , RNA Mensageiro/genética , Reação em Cadeia da Polimerase em Tempo Real , População Rural , Adulto Jovem
2.
J Glaucoma ; 18(3): 197-200, 2009 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19295371

RESUMO

PURPOSE: Subclinical inflammation may be observed in patients using topical antiglaucomatous drugs. The objective of this study was to investigate inflammation in conjunctiva of glaucoma patients using prostaglandin analogs, by the detection of an immunogenetic marker (HLA-DR) and compare the effect of 3 different drugs: latanoprost, bimatoprost, and travoprost in the induction of this inflammation. SUBJECTS AND METHODS: Thirty-three patients with primary open-angle glaucoma were evaluated without and with prostaglandin analogs topical therapy. Imprints of conjunctival cells were obtained, fixed on glass slides, and prepared for immunohistochemical analysis. RESULTS: Before the use of prostaglandin analogs, 4 of the 33 patients evaluated presented expression of HLA-DR in the conjunctiva (mild). After 1 month on prostaglandin analog treatment, all but 1 patient presented HLA-DR staining. HLA-DR expression of these 32 patients was scored as mild (19 patients), medium (11 patients), or intense (2 patients). The differences were statistically significant both when the presence and the increased expression of HLA-DR were considered (P<0.001). When the 3 different groups were analyzed (latanoprost, bimatoprost, and travoprost) no statistically significant difference was found (P=0.27). CONCLUSIONS: The use of prostaglandin analogs eye drops provokes a subclinical inflammatory reaction, observed by HLA-DR expression, even after a short period of treatment, independently of the class of the prostaglandin analogs used.


Assuntos
Anti-Hipertensivos/efeitos adversos , Biomarcadores/metabolismo , Conjuntivite/induzido quimicamente , Conjuntivite/metabolismo , Glaucoma de Ângulo Aberto/tratamento farmacológico , Antígenos HLA-DR/metabolismo , Administração Tópica , Idoso , Idoso de 80 Anos ou mais , Amidas/efeitos adversos , Amidas/uso terapêutico , Anti-Hipertensivos/uso terapêutico , Bimatoprost , Cloprostenol/efeitos adversos , Cloprostenol/análogos & derivados , Cloprostenol/uso terapêutico , Feminino , Humanos , Técnicas Imunoenzimáticas , Latanoprosta , Masculino , Pessoa de Meia-Idade , Prostaglandinas F Sintéticas/efeitos adversos , Prostaglandinas F Sintéticas/uso terapêutico , Travoprost
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA